Table 3 Molecular diagnosis rates by age and phenotype groups
From: The genomic landscape of rare disorders in the Middle East
| Â | Neurological | Non-neurological | Overall | |||
|---|---|---|---|---|---|---|
Total no. | %Positive (95% CI) | Total no. | %Positive (95% CI) | Total no. | %Positive (95% CI) | |
Age, years | ||||||
 0–2 | 223 | 40.4% (34.1–46.9) | 209 | 34.9% (28.8–41.6) | 432 | 37.7% (33.3–42.4) |
 2–5 | 132 | 28.0% (21.1–36.2) | 71 | 33.8% (23.9–45.4) | 203 | 30.0% (24.2–36.7) |
 ≥ 5 | 185 | 25.4% (19.7–32.1) | 180 | 30.0% (23.8–37.1) | 365 | 27.7% (23.3–32.5) |
Overall | 540 | 32.2% (28.4–36.3) | 460 | 32.8% (28.7–37.2) | 1000 | 32.5% (29.7–35.5) |